Analysis of megakaryocyte ploidy in patients with thrombocytosis.
The DNA content of bone marrow megakaryocytes was analyzed in 24 patients with myeloproliferative disorders, 23 patients with secondary thrombocytosis and 15 normal volunteers using 2-color flow cytometry. Compared with normal controls, the majority of patients with secondary thrombocytosis, polycythemia vera and essential thrombocytosis exhibited a relative increase in higher ploidy (greater than 16N) cells. In contrast, patients with chronic myelogenous leukemia exhibited an increase in lower ploidy cells (less than 16N), with a modal DNA content of 8N. Patients with myeloproliferative disorders tended to show a decrease in the 16N megakaryocyte population compared with patients with secondary thrombocytosis. No correlation between ploidy distribution and platelet count was observed.
Kanz
L
L
Medizinische Universitatsklinik Freiburg, Department of Hematology and Oncology, Federal Republic of Germany.
Hollen
C
C
Friese
P
P
Burstein
S A
SA
D001853:Bone Marrow / Q000473:pathology; D005434:Flow Cytometry; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000473:pathology; D008533:Megakaryocytes / Q000473:pathology*; D009196:Myeloproliferative Disorders / Q000235:genetics / Q000473:pathology; D011003:Ploidies; D012016:Reference Values; D013922:Thrombocytosis / Q000235:genetics / Q000473:pathology*